Related Experiment Video
Updated: Jul 9, 2026
10:46
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings
Published on: September 1, 2023
Weight issues for people with epilepsy--a review.
1Department of Clinical Neuroscience and Physiology, Sahlgenska University Hospital, Göteborg University, Göteborg, Sweden. ebm@neuro.gu.se
Epilepsia
|December 6, 2007
Summary
Certain antiepileptic drugs (AEDs) can cause significant weight changes, impacting patient health and treatment adherence. Careful patient monitoring and individualized drug selection are crucial for managing epilepsy effectively.
Area of Science:
- Neurology
- Pharmacology
- Metabolic Health
Background:
- Epilepsy management involves long-term pharmacological treatment with antiepileptic drugs (AEDs).
- Weight fluctuations are a potential side effect of some AEDs, impacting patient morbidity and treatment adherence.
- Lifestyle factors like sedentary behavior can also contribute to weight gain in individuals with epilepsy.
Purpose of the Study:
- To categorize AEDs based on their association with weight loss, weight gain, or weight neutrality.
- To highlight the clinical significance of weight changes in epilepsy patients undergoing pharmacological treatment.
- To emphasize the importance of regular patient weight monitoring and personalized AED selection.
Main Methods:
- Review of existing literature on AEDs and their effects on body weight.
- Classification of commonly prescribed AEDs according to their documented impact on weight.
- Analysis of the clinical implications of AED-induced weight changes.
Main Results:
- AEDs associated with weight loss include felbamate, topiramate, and zonisamide.
- AEDs associated with weight gain include gabapentin, pregabalin, valproic acid, vigabatrin, and possibly carbamazepine.
- Weight-neutral AEDs identified are lamotrigine, levetiracetam, and phenytoin.
Conclusions:
- AEDs have variable effects on body weight, necessitating careful consideration during treatment.
- Regular monitoring of weight is essential for patients with epilepsy on AED therapy.
- Individualized selection of AEDs, considering weight effects, is critical to optimize therapeutic efficacy and patient outcomes.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.